Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Incorporation of Antimicrobial Agents in Nasal Sprays

Posted on By




SOP for Incorporation of Antimicrobial Agents in Nasal Sprays



Standard Operating Procedure for Incorporation of Antimicrobial Agents in Nasal Sprays

1) Purpose

This SOP outlines the procedures for incorporating antimicrobial agents in nasal spray formulations to enhance the product’s stability and prevent microbial contamination during use. Antimicrobial agents ensure product safety for long-term use.

2) Scope

This SOP applies to personnel involved in the formulation, preparation, and quality control of nasal sprays containing antimicrobial agents at [Company Name]. It covers the selection, weighing, and testing of antimicrobial agents in nasal sprays.

3) Responsibilities

  • Operators: Responsible for accurately weighing and incorporating antimicrobial agents into nasal spray formulations.
  • Quality Assurance (QA): Ensures that the antimicrobial agents are evenly distributed in the formulation and that the product meets microbial stability standards.
  • Maintenance Team: Ensures all equipment used in the formulation process is clean, calibrated, and maintained.

4) Procedure

4.1 Preparation of Ingredients

4.1.1 Selection of Antimicrobial Agents

  • Select appropriate antimicrobial agents based on the formulation’s intended use and regulatory guidelines. Common agents include benzalkonium chloride, phenoxyethanol, and parabens.
  • Document the selection of antimicrobial agents in the batch manufacturing record (BMR) and ensure their concentrations fall within regulatory limits.

4.1.2 Weighing of Ingredients

  • Weigh the antimicrobial agents using a calibrated balance. Record the weights in the BMR, ensuring accuracy within ±2% of the target weight.
  • Transfer the weighed antimicrobial agents to a clean, sterile mixing vessel.
See also  SOP for SOP for pH and Osmolality Control in N...

4.2 Incorporation of Antimicrobial Agents

4.2.1 Addition to Aqueous Phase

  • For solution-based nasal sprays, dissolve the antimicrobial agents in the aqueous phase. Stir continuously using a mechanical stirrer until the agents are fully dissolved and uniformly distributed.
  • Document the stirring speed and time in the BMR. Ensure no residual solids or undissolved agents remain in the solution.

4.2.2 Testing for Uniformity

  • Take samples from different points in the mixing vessel to test the uniform distribution of antimicrobial agents. Use a validated method (e.g., HPLC or UV spectrophotometry) to measure the concentration of antimicrobial agents across the samples.
  • Document the results in the homogeneity testing log, ensuring the deviation does not exceed 2%.

4.3 Filling and Packaging

4.3.1 Filling Process

  • Transfer the prepared nasal spray formulation into the filling machine. Set the machine to dispense the required dose per unit (e.g., 50 µL per spray).
  • Test the fill accuracy by weighing 10 randomly selected filled units. The variation should not exceed ±5% of the target dose. Document the results in the BMR.

4.3.2 Packaging and Labeling

  • Seal the filled nasal spray containers with sterile caps or nozzles. Ensure that the containers are free from leaks and defects before packaging.
  • Label the containers with batch numbers, expiration dates, and instructions for use. Package the containers in protective packaging to prevent contamination during storage and distribution.
See also  SOP for Incorporating Anti-Inflammatory Agents in Nasal Sprays

4.4 Quality Control

4.4.1 Microbial Stability Testing

  • Test the microbial stability of the nasal spray by performing preservative efficacy testing (PET) in accordance with pharmacopeial guidelines (e.g., USP <51>). Record the results in the preservative efficacy testing log.

4.4.2 Stability Testing

  • Conduct long-term and accelerated stability testing to assess the physical and chemical stability of the product. Store samples under controlled environmental conditions (e.g., 25°C, 60% RH) and test at regular intervals (e.g., 1 month, 3 months, 6 months).
  • Record all test results in the stability testing log and adjust the expiration date as needed based on the stability findings.

4.5 Documentation

  • Document all steps of the formulation process in the BMR, including the weighing of ingredients, mixing process, and testing results.
  • Ensure QA personnel review and sign off on all documentation before product release.

4.6 Equipment Cleaning and Calibration

  • Clean and sterilize all equipment used in the preparation of the nasal spray formulation, including mixers and filling machines, as per the cleaning validation protocol.
  • Calibrate the equipment as per the calibration schedule and record the results in the cleaning and calibration logs.

5) Abbreviations, if any

  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • Preservative Efficacy Testing Log
  • Homogeneity Testing Log
  • Stability Testing Log
  • Cleaning Log
  • Calibration Log

7) References, if any

  • USP <51> – Antimicrobial Effectiveness Testing
  • FDA Guidance for Nasal Drug Products

8) SOP Version

Version 1.0

Annexure

1. Preservative Efficacy Testing Log Template

Date Formulation Preservative Microbial Count Reduction (%) Operator Initials QA Approval
DD/MM/YYYY Formulation Name Preservative Name Initial You said: Continue ChatGPT said: ChatGPT html Copy code Microbial Count (%) Operator Name QA Name
           

2. Homogeneity Testing Log Template

Date Formulation Test Point (Top/Middle/Bottom) Antimicrobial Agent Concentration (%) Operator Initials QA Approval
DD/MM/YYYY Formulation Name Test Point Concentration Operator Name QA Name
           

3. Stability Testing Log Template

Date Formulation Storage Conditions Time Interval Stability Results Operator Initials QA Approval
DD/MM/YYYY Formulation Name Temperature and Humidity 1 month, 3 months, etc. Pass/Fail Operator Name QA Name
           

4. Cleaning Log Template

Date Equipment ID Cleaning Procedure Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Cleaning Method Operator Name QA Name
           

5. Calibration Log Template

Date Equipment ID Calibration Procedure Calibration Results Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Calibration Method Pass/Fail Operator Name QA Name
           


See also  SOP for Incorporation of Biodegradable Polymers in Nasal Sprays
Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Weighing and Dispensing of Lipid and Aqueous Components
Next Post: SOP for Preparation of Protein-Based Lyophilized Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version